Search research articles
Contact Us
Filters
Showing results (31-40 of 72) with videos related to
Page
of 8
Sort By:
Hepatology (Baltimore, Md.)
|
February 12, 2025
Erratum: Resmetirom therapy for metabolic dysfunction-associated steatotic liver disease: October 2024 updates to AASLD Practice Guidance
Vincent L Chen, Timothy R Morgan, Yaron Rotman, et al.
Hepatology (Baltimore, Md.)
|
October 18, 2024
Resmetirom therapy for metabolic dysfunction-associated steatotic liver disease: October 2024 updates to AASLD Practice Guidance
Vincent L Chen, Timothy R Morgan, Yaron Rotman, et al.
Hepatology (Baltimore, Md.)
|
February 14, 2025
Reply: AASLD Resmetirom Guidance
Vincent L Chen, Timothy R Morgan, Yaron Rotman, et al.
Journal of Toxicology and Environmental Health. Part A
|
November 27, 2014
Kidney biomarkers associated with blood lead, mercury, and cadmium in premenopausal women: a prospective cohort study
Anna Z Pollack, Sunni L Mumford, Pauline Mendola, et al.
Gastroenterology
|
January 18, 2012
HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons
Emmanuel Thomas, Veronica D Gonzalez, Qisheng Li, et al.
Hepatology Communications
|
April 16, 2021
Lipoprotein Insulin Resistance Index Reflects Liver Fat Content in Patients With Nonalcoholic Fatty Liver Disease
Anusha Vittal, Mark Shapses, Bashar Sharma, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
November 26, 2019
Dietary fatty acid oxidation is decreased in non-alcoholic fatty liver disease: A palmitate breath test study
Gihan Naguib, Nevitt Morris, Shanna Yang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 8, 2019
Rhythmic Fluctuations in Levels of Liver Enzymes During Menstrual Cycles of Healthy Women and Effects of Body Weight
Chunwei Walter Lai, Sneha Jadhav, Basile Njei, et al.
Purinergic Signalling
|
July 29, 2020
Design and in vivo activity of A<sub>3</sub> adenosine receptor agonist prodrugs
R Rama Suresh, Shanu Jain, Zhoumou Chen, et al.
Journal of Lipid Research
|
September 25, 2020
Characterization of essential domains in HSD17B13 for cellular localization and enzymatic activity
Yanling Ma, Suman Karki, Philip M Brown, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 72) with videos related to
Sort By:
Page
of 8
Hepatology (Baltimore, Md.)
|
February 12, 2025
Erratum: Resmetirom therapy for metabolic dysfunction-associated steatotic liver disease: October 2024 updates to AASLD Practice Guidance
Vincent L Chen, Timothy R Morgan, Yaron Rotman, et al.
Hepatology (Baltimore, Md.)
|
October 18, 2024
Resmetirom therapy for metabolic dysfunction-associated steatotic liver disease: October 2024 updates to AASLD Practice Guidance
Vincent L Chen, Timothy R Morgan, Yaron Rotman, et al.
Hepatology (Baltimore, Md.)
|
February 14, 2025
Reply: AASLD Resmetirom Guidance
Vincent L Chen, Timothy R Morgan, Yaron Rotman, et al.
Journal of Toxicology and Environmental Health. Part A
|
November 27, 2014
Kidney biomarkers associated with blood lead, mercury, and cadmium in premenopausal women: a prospective cohort study
Anna Z Pollack, Sunni L Mumford, Pauline Mendola, et al.
Gastroenterology
|
January 18, 2012
HCV infection induces a unique hepatic innate immune response associated with robust production of type III interferons
Emmanuel Thomas, Veronica D Gonzalez, Qisheng Li, et al.
Hepatology Communications
|
April 16, 2021
Lipoprotein Insulin Resistance Index Reflects Liver Fat Content in Patients With Nonalcoholic Fatty Liver Disease
Anusha Vittal, Mark Shapses, Bashar Sharma, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
November 26, 2019
Dietary fatty acid oxidation is decreased in non-alcoholic fatty liver disease: A palmitate breath test study
Gihan Naguib, Nevitt Morris, Shanna Yang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 8, 2019
Rhythmic Fluctuations in Levels of Liver Enzymes During Menstrual Cycles of Healthy Women and Effects of Body Weight
Chunwei Walter Lai, Sneha Jadhav, Basile Njei, et al.
Purinergic Signalling
|
July 29, 2020
Design and in vivo activity of A<sub>3</sub> adenosine receptor agonist prodrugs
R Rama Suresh, Shanu Jain, Zhoumou Chen, et al.
Journal of Lipid Research
|
September 25, 2020
Characterization of essential domains in HSD17B13 for cellular localization and enzymatic activity
Yanling Ma, Suman Karki, Philip M Brown, et al.
Page
of 8